Last reviewed: June 17, 2026
Last updated: June 17, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Zepbound (tirzepatide) and Wegovy (semaglutide) have transformed weight loss treatment by targeting appetite-regulating hormones in the brain and gut. While both are GLP-1 receptor agonists, tirzepatide adds a second mechanism by activating GIP receptors, potentially offering distinct benefits for different patients. Choosing between them depends on your individual health profile, response patterns, and metabolic needs.
Understanding Tirzepatide and Semaglutide Mechanisms
Semaglutide, the active ingredient in Wegovy, works by mimicking glucagon-like peptide-1 (GLP-1), a natural hormone that signals fullness to your brain and slows stomach emptying. This single-pathway activation has shown consistent results in clinical trials, with patients losing an average of 15-22% of body weight over 68 weeks. The mechanism is well-established and has been studied for over a decade in diabetes and weight management populations.
Tirzepatide, found in Zepbound, activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously. This dual-action approach engages more of your body's natural appetite and metabolic regulation systems. In the SURMOUNT-1 trial, tirzepatide demonstrated weight loss ranging from 21-22.5% depending on dose, with some patients achieving losses exceeding 25% of baseline body weight.
Clinical Trial Results: Direct Weight Loss Comparisons
Head-to-head trial data shows tirzepatide generally produces numerically greater weight reduction than semaglutide at comparable dosing timepoints. In SURMOUNT trials, the highest tirzepatide dose resulted in approximately 22.5% weight loss, while Wegovy's pivotal trial showed approximately 15% weight loss at standard doses. However, individual responses vary significantly based on genetics, lifestyle, and metabolic factors that affect how well each medication works for your body.
Both medications improve blood sugar control, reduce cardiovascular risk markers, and show benefits for heart health in secondary analyses. The choice between them often comes down to personal tolerance, side effect profiles, and how your specific genetic makeup responds to GLP-1 versus dual GLP-1/GIP activation. Some patients achieve excellent results with semaglutide alone, while others see superior outcomes with tirzepatide's dual mechanism.
Side Effects and Tolerability Differences
Both tirzepatide and semaglutide commonly cause gastrointestinal effects including nausea, vomiting, and constipation, particularly during dose escalation phases. These side effects typically decrease over time as your body adapts to the medication. Most patients experience mild to moderate GI effects that become manageable with dietary adjustments and gradual dose increases, though individual tolerance varies widely.
Tirzepatide's dual-receptor activation may cause slightly different side effect patterns compared to semaglutide. Some patients report stronger appetite suppression with tirzepatide, which can be beneficial for weight loss but may require more attention to nutrition intake. Others find one medication more tolerable than the other based on their unique physiology and how their body responds to GLP-1 versus GIP pathway activation.
Personalized GLP-1 Therapy at PlexusDx
PlexusDx offers both compounded semaglutide and tirzepatide injections, giving patients access to either mechanism based on individual needs and preferences. Compounded tirzepatide injections start at $249 per month with flat pricing across three commitment tiers—your dose may need to go up, but your price won't. PlexusDx also offers oral tirzepatide at $279 per month for patients who prefer tablets, plus GLP-Squared formulations combining both compounds for advanced metabolic support.
For patients seeking precision guidance, the Precision Peptide Genetic Test ($99 add-on after the first month of treatment) analyzes how your genetic variants in GLP1R, GIPR, FTO, and MC4R pathways influence medication response. This genetic insight, mapping 14 metabolic pathways and 150+ individual peptide interactions, helps PlexusDx providers match you with tirzepatide, semaglutide, or combination therapy most likely to succeed based on your biology. All PlexusDx medications come from licensed 503A compounding pharmacies, are available in all 50 states without insurance, and are HSA/FSA eligible.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Which medication causes more weight loss: Zepbound or Wegovy?
Clinical trials show tirzepatide (Zepbound) produces slightly greater average weight loss (21-22.5%) compared to semaglutide (Wegovy) at 15-17%, but individual results vary significantly. Your genetic makeup, lifestyle, and metabolic factors determine which medication works best for you personally.
How do GLP-1 and GIP receptors work differently in the body?
GLP-1 receptors signal fullness and slow digestion through well-studied pathways. GIP receptors also regulate blood sugar and energy metabolism, offering an additional lever for appetite control. Activating both pathways simultaneously (tirzepatide) engages more of your body's natural weight regulation systems compared to GLP-1 alone.
Can I switch from Wegovy to Zepbound if one doesn't work?
Yes, many patients transition between semaglutide and tirzepatide based on tolerance and results. PlexusDx providers can help you switch medications safely while maintaining consistent dosing schedules and monitoring for side effects during the transition.
What are the most common side effects, and do they go away?
Nausea, vomiting, and constipation are most common, especially during dose increases, but typically improve within weeks as your body adjusts. Staying hydrated, eating protein-rich foods, and increasing fiber intake help manage GI effects. Serious side effects are rare but should be reported to your provider immediately.
How does the Precision Peptide Genetic Test help choose between tirzepatide and semaglutide?
The test analyzes your GLP1R and GIPR genetic variants along with 47 other peptide-pathway genes to predict how strongly you'll respond to each mechanism. Patients with certain GLP1R variants may respond excellently to semaglutide, while those with stronger GIPR activation potential often benefit from tirzepatide's dual approach, personalizing your medication selection based on genetics.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Do You Lose Weight on Wegovy Without Dieting? Exploring the Science and Realities
What Weight Do You Have to Be to Get Ozempic?